BioSyent Inc. (RX:CA) Q4 2025 Earnings Call Prepared Remarks Transcript
Seeking Alpha·2026-03-24 17:24
PresentationRené GoehrumChairman, CEO & President Hello. Welcome to the Q4 and Full Fiscal Year 2025 Results Presentation for BioSyent Inc. My name is René Goehrum, and I'm the President and CEO of the company. Today, you'll hear that we closed out a very solid year in 2025. And today's presentation will touch on our recent Oral Science acquisition, but the results that I'll be reviewing with you are for the period ended December 31, 2025, which is before our March acquisition date of Oral Science. I will ...